145 related articles for article (PubMed ID: 32433174)
21. Unusual Uptake of 131I in a Cutaneous Benign Fibrous Histiocytoma in a Patient With Thyroid Cancer.
Zhou H; Yan J; Huang R; Li L
Clin Nucl Med; 2018 Jan; 43(1):e31-e32. PubMed ID: 29076899
[TBL] [Abstract][Full Text] [Related]
22. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
[TBL] [Abstract][Full Text] [Related]
23. An Unusual False-Positive Uptake of Radioiodine Caused by Metallic Implants.
Liu L; Chen Y; Tian T; Huang R; Liu B
Clin Nucl Med; 2019 Aug; 44(8):e495-e496. PubMed ID: 31274633
[TBL] [Abstract][Full Text] [Related]
24. Rate of elimination of radioiodine-avid lymph node metastases of differentiated thyroid carcinoma by postsurgical radioiodine ablation. A bicentric study.
Ilhan H; Mustafa M; Bartenstein P; Kuwert T; Schmidt D
Nuklearmedizin; 2016 Dec; 55(6):221-227. PubMed ID: 27588323
[TBL] [Abstract][Full Text] [Related]
25. Focally Increased Iodine Activity in a Small Thymic Cyst.
Liu Y; Bai X; Mu D; Wang J; Lou C
Clin Nucl Med; 2019 Jun; 44(6):477-479. PubMed ID: 30789398
[TBL] [Abstract][Full Text] [Related]
26. Unusual Uptake of Radioiodine in a Subcutaneous Lipoma in a Patient With Differentiated Thyroid Cancer.
Shen G; Jing X; Zhang Y; Kuang A; Huang R
Clin Nucl Med; 2017 Jan; 42(1):e75-e76. PubMed ID: 27556799
[TBL] [Abstract][Full Text] [Related]
27. Hiatal hernia on whole-body radioiodine survey mimicking metastatic thyroid cancer.
Schneider JA; Divgi CR; Scott AM; Macapinlac HA; Sonenberg M; Goldsmith SJ; Larson SM
Clin Nucl Med; 1993 Sep; 18(9):751-3. PubMed ID: 8403716
[TBL] [Abstract][Full Text] [Related]
28. Use of
Wu D; Ylli D; Gomes Lima CJ; Lee W; Burman KD; Wartofsky L; Van Nostrand D
Endocrine; 2018 Oct; 62(1):57-63. PubMed ID: 29797211
[TBL] [Abstract][Full Text] [Related]
29. False-Positive Uptake of 131I From Basal Cell Papilloma in a Patient With Metastatic Papillary Thyroid Cancer.
Luo L; Wang J; Xia J; Zhang R; Yao X
Clin Nucl Med; 2021 Apr; 46(4):358-360. PubMed ID: 33492860
[TBL] [Abstract][Full Text] [Related]
30. Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?
Giammarile F; Hafdi Z; Bournaud C; Janier M; Houzard C; Desuzinges C; Itti R; Sassolas G; Borson-Chazot F
Eur J Endocrinol; 2003 Oct; 149(4):293-300. PubMed ID: 14514343
[TBL] [Abstract][Full Text] [Related]
31. Unexpected Retrosternal Goiter Interpreted as Hyperfunctioning Metastasis on the Posttherapeutic 131I SPECT/CT.
Hou LY; Luo QY; Qiu ZL
Clin Nucl Med; 2022 Mar; 47(3):258-259. PubMed ID: 34661561
[TBL] [Abstract][Full Text] [Related]
32. Incidental finding of a dermoid cyst in a whole-body iodine scan: importance of using [131I]SPECT/CT in the differentiated thyroid carcinoma.
Mohammadzadeh Kosari H; Zakavi SR; Barashki S; Roustaei Firouzabad H; Ataei Nakhaei S; Aryana K
Nucl Med Rev Cent East Eur; 2021; 24(2):106-107. PubMed ID: 34382676
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of SPECT/CT for equivocal findings on (131)I whole-body scan in a patient with differentiated papillary thyroid cancer.
Choi B; Kim DH; Son SH; Zeon S; Ahn BC
Clin Nucl Med; 2014 Feb; 39(2):e160-2. PubMed ID: 23531738
[TBL] [Abstract][Full Text] [Related]
34. Esophageal metastasis from papillary thyroid cancer: diagnosis by 131I SPECT/CT.
Wisotzki C; Friese M; Ehresmann J; Derlin T
Clin Nucl Med; 2014 Jan; 39(1):e73-4. PubMed ID: 23455522
[TBL] [Abstract][Full Text] [Related]
35. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer.
Samanci C; Onal Y; Sager S; Asa S; Ustabasioglu FE; Alis D; Akman C; Sonmezoglu K
Curr Med Imaging Rev; 2019; 15(10):956-964. PubMed ID: 32008523
[TBL] [Abstract][Full Text] [Related]
37. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
[TBL] [Abstract][Full Text] [Related]
38. False-positive radioiodine uptake in a functional ovarian cyst in a patient treated with total thyroidectomy for papillary cancer.
Jang HY; Kim BH; Kim WJ; Jeon YK; Kim SS; Kim YK; Kim IJ
Intern Med; 2013; 52(20):2321-3. PubMed ID: 24126393
[TBL] [Abstract][Full Text] [Related]
39. Cervicomediastinal magnetic resonance imaging in persistent or recurrent papillary thyroid carcinoma: clinical use and limits.
Toubert ME; Cyna-Gorse F; Zagdanski AM; Noel-Wekstein S; Cattan P; Billotey C; Sarfati E; Rain JD
Thyroid; 1999 Jun; 9(6):591-7. PubMed ID: 10411122
[TBL] [Abstract][Full Text] [Related]
40. Clinical Value of
Gao R; Zhang GJ; Wang YB; Liu Y; Wang F; Jia X; Liang YQ; Yang AM
Sci Rep; 2018 Jan; 8(1):473. PubMed ID: 29323252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
